Patents
Patents for C07D 453 - Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids (5,704)
12/2008
12/16/2008CA2398887C 2,4,di(hetero-)arylamino(-oxy)-5-substituted pyrimidines as antineoplastic agents
12/16/2008CA2285817C Novel basic derivatives of benz[e]isoindol-1-ones and pyrrolo[3,4-c] quinolin-1-ones with 5-ht3-antagonistic activity, their preparation and their therapeutic use
12/10/2008EP1396487B1 Phenylpyridine carbonyl piperazine derivative
12/09/2008US7462722 3-quinuclidinone or the salt reacted with hydrogen in the presence of a basic compound, a complex of a transition metal with ligand such as 2,2'-bis(diphenylphosphino)-5,5',6,6',7,7',8,8'-octahydro-1,1'-binaphthyl- and optically active 1,2-butanediamines
12/09/2008US7462628 Preventives/remedies for urinary disturbance
12/04/2008WO2008146774A1 Tetrahydroisoquinolin-1-one derivative or salt thereof
12/04/2008WO2008145243A1 Pyridazinone derivatives
12/04/2008CA2688518A1 Pyridazinone derivatives for use in the treatment of a disease which is influenced by inhibiton of met kinase
12/04/2008CA2688326A1 Tetrahydroisoquinolin-1-one derivative or salt thereof
12/03/2008EP1997495A1 2-phenoxy- and 2-phenylsulfanyl-benzenesulfonamide derivatives with ccr3 antagonistic activity for the treatment of asthma and other inflammatory or immunological disorders
12/03/2008EP1996585A2 Bicycloheteroaryl compounds as p2x7 modulators and uses thereof
12/03/2008EP1480954B1 Vanilloid receptor modulators
12/03/2008EP1028961B3 Pleuromutilin derivatives as antimicrobials
12/03/2008CN101316828A Method for preparing N-triazine radical ammonium salt
12/03/2008CN101314601A Preparation process of high-purity palonosetron Hcl
11/2008
11/27/2008US20080294289 Preparation and Use of Alkylating Agents
11/26/2008EP1994015A1 Dibenzyl amine derivatives as cetp inhibitors
11/26/2008CN101312968A Indazoles, benzothiazoles, benzoisothiazoles, benzisoxazoles, pyrazolopyridines, isothiazolopyridines, and preparation and uses thereof
11/25/2008US7456206 Biaryl heterocyclic compounds and methods of making and using the same
11/25/2008CA2449922C Pharmaceutical composition for therapy of interstitial cystitis
11/20/2008WO2008062282A3 An improved process for the synthesis of solifenacin
11/20/2008US20080287680 Solifenacin Succinate-Containing Composition
11/20/2008US20080287487 Muscle relaxants; respiratory system disorders; asthma; COPD; emphysema; bronchitis
11/18/2008US7452997 Tetrahydro-indazole cannabinoid modulators
11/18/2008US7452911 Alkyne compounds with MCH antagonistic activity and medicaments comprising these compounds
11/18/2008US7452904 1-alkyl-1-azoniabicyclo' 2.2.2 octane carbamate derivatives and their use as muscarinic receptor antagonists
11/18/2008CA2331850C Method of preparing carboxylic acid derivatives and condensing agent comprising a quaternary ammonium salt
11/12/2008EP1989185A1 Therapeutic compounds
11/11/2008US7449489 e.g. isopropyl [({2-[5-[2-(2-azabicyclo[2.2.2]oct-2-yl)- 1,1-dimethyl-2-oxoethyl]-2-(3,5-dimethylphenyl)-1H-indol-3-yl]propyl }amino)(3-pyridin-4-ylpyrrolidin-1-yl)methylene]carbamate; gonadotrophin releasing hormone antagonists; anticarcinogenic agent; breast, prostate, uretus cancer
11/11/2008US7449478 Treatment of peroxisome proliferation activated receptor diseases such as diabetes, skin disorders or high blood pressure
11/11/2008US7449457 Substituted heterocyclic carboxamides with antithrombotic activity
11/11/2008US7449456 signal transducer and activator of transcription-6 inhibitors; asthma, COPD, respiratory, inflammatory and allergic diseases; compounds have less suppressive effect on immunological functions; 4-[(2,5 -difluorobenzyl) amino]-2-[(4-morpholin-4-ylphenyl)amino]pyrimidine-5 -carboxamide
11/06/2008WO2008132679A1 Bridged six-membered ring compounds
11/06/2008US20080275003 Phospholipase inhibitor; prevention or therapy of microbial infection; bactericides; fungicides; viricides; parasiticides; using quaternary or phosphonium group containing compounds
11/06/2008CA2683866A1 Bridged six-membered ring compounds
11/05/2008EP1988075A1 Pyrrole derivative or salt thereof
11/05/2008EP1987029A1 Enantiopure quinuclidinyloxy pyridazines and their use as nicotinic acetylcholine receptor ligands
11/05/2008EP1987006A1 Novel aminoalcohol-substituted aryldihydroisoquinolinones, process for their preparation and their use as medicaments
11/05/2008EP1608374B1 2-phenoxy- and 2-phenylsulfomamide derivatives with ccr3 antagonistic activity for the treatment of asthma and other inflammatory or immunological disorders
11/05/2008EP1319000B1 Use of 1-azabicyclo 2.2.2 octan-3-one derivatives for treating cancer tumors
11/05/2008CN101298433A 2-, 3-, 4-, or 5-substituted-n1-(benzensulfonyl)indoles and their use in therapy
10/2008
10/30/2008WO2008129054A2 Heterocyclic compounds with affinity to muscarinic receptors
10/30/2008US20080269221 Antibacterial agents
10/30/2008US20080269207 Anticancer agents; such as 4-acetylamino-1H-pyrazole-3-carboxylic acid (4-fluoro-phenyl)-amide
10/30/2008CA2682994A1 Heterocyclic compounds with affinity to muscarinic receptors
10/29/2008EP1660474B1 Substituted thiophenes and uses thereof
10/28/2008US7442794 Stereoisomers ; reacting with Lewis acid; purification
10/23/2008US20080262030 Drug for psychological and central nervous system disorders
10/23/2008US20080262023 Aminomethyl Azaadamantane Derivatives and Methods of Use Thereof
10/22/2008EP1417196B1 Dna-pk inhibitors
10/21/2008US7439256 (Arylamidoaryl) cyanoguanidine compounds
10/16/2008US20080255135 1-Aza-bicyclo[2.2.2]octane and 1-aza-bicyclo[2.2.1]heptane derivatives; psychotic, psychological, nervous system and neurodegenerative disorders; nicotinic receptor mediated diseases
10/16/2008US20080255114 2-aminobenzoxazole carboxamides as 5ht3 modulators
10/15/2008EP1980252A2 Pharmaceutical compositions comprising dextromethorphan and quinidine for the treatment of neurological disorders
10/15/2008EP1411940B1 Bridged piperidine derivatives as melanocortin receptor agonists
10/14/2008US7435742 potent antagonists of M3 muscarinic receptors; chronic obstructive pulmonary disease; bronchitis, bronchial hyperreactivity, asthma, cough and rhinitis; gastrointestinal disorders; incontinenc; [2-(3,4-Dimethoxyphenyl)ethyl]-(5-methylfuran-2-ylmethyl)carbamic acid (3R)-1 -azabicyclo[2.2.2]oct-3-yl ester
10/09/2008WO2008120080A2 An improved process for the synthesis of solifenacin
10/09/2008US20080249312 Process for the preparation of 2-methylspiro(1,3-oxathiolane-5,3')quiniclidine
10/09/2008US20080247963 Quinuclidine Compounds Having Quaternary Ammonium Group, Its Preparation Method and Use as Blocking Agents of Acetylcholine
10/09/2008CA2682381A1 An improved process for the synthesis of solifenacin
10/08/2008EP1633348B1 4- BROMO - 5 - (2- CHLORO - BENZOYLAMINO) - 1H - PYRAZOLE - 3 - CARBOXYLIC ACID AMIDE DERIVATIVES AND RELATED COMPOUNDS AS BRADYKININ B sb 1 /sb RECEPTOR ANTAGONISTS FOR THE TREATMENT OF INFLAMMATORY DISEASES
10/07/2008US7432400 sun protection agents; diketone
10/07/2008US7432379 3-Amido-5-substituted pyrazole derivatives and related compounds useful as bradykinin B1 receptor antagonists to relieve adverse symptoms in mammals mediated, at least in part, by bradykinin B1 receptor including pain, inflammation, septic shock, scarring process
10/07/2008US7432280 3-aminopiperidines and 3-aminoquinuclidines as inhibitors of monoamine uptake
10/04/2008CA2584349A1 Process for the preparation of 2-methylspiro(1,3-oxathiolane-5,3') quiniclidine
10/02/2008US20080242697 Reacting 3-quinuclidinol with 1,3-carbonyldi(1,2,4triazole) in solvent; then 1,2,3,4-tetrahydroisoqionoline; isolation; purification
10/01/2008EP1973904A2 Muscarinic agonists and methods of use thereof
09/2008
09/30/2008US7429664 Indazoles, benzothiazoles, and benzoisothiazoles, and preparation and uses thereof
09/25/2008US20080234316 Quinuclidine Amide Derivatives
09/18/2008WO2008112900A1 Dibenzo[b,f][1,4]oxazapine compounds
09/18/2008US20080227809 hexaquis(3-phenyl-propylamine) decavanadate (V); particularly insulin-resistant diabetes; insulin mimickers
09/18/2008US20080227785 BEC 1 potassium channel inhibitors, used to treat dementia and learning disorders; e.g., N-(4-fluorophenyl)-N'-isopropyl-N''-phenyl-1,3,5-triazine-2,4,6-triamine hydrochloride
09/18/2008US20080227683 Compounds Having Antitumor Activity
09/18/2008CA2678897A1 Dibenzo[b,f][1,4]oxazapine compounds
09/17/2008CN101268071A Novel 1-aza bicycloalkyl derivatives for the treatment of psychotic and neurodegenerative disorders
09/17/2008CN100418964C Process for the preparation of (S,S)-cis-2-benzhydryl-3-benzylaminoquinuclidine
09/16/2008US7425561 3-substituted-2(arylalkyl)-1-azabicycloalkanes and methods of use thereof
09/12/2008WO2008107545A1 Novel quinuclidine derivative useful in the preparation of mequitazine
09/12/2008CA2675118A1 Novel quinuclidine derivative useful in the preparation of mequitazine
09/11/2008US20080221331 Azabicyclo[3.3.1]nonane N-oxyl having an N-oxyl group incorporated; pharmaceuticals, perfume and liquid crystal; low environmental burden, can be supplied in a large amount at a low cost
09/11/2008US20080221330 14-{(3S,4S)-1-azabicyclo[2.2.1]heptane-3-carbonyl}carbamoyl-12-desethenyl-3-methoxy-11-O-methoxymethyl-11-oxo-12-[2-propene-3-yl]-4-epimutilin; strong antimicrobial activity against abroad spectrum of Gram-positive or Gram-negative bacteria
09/11/2008US20080221155 Novel quinuclidine derivatives and medicinal compositions containing the same
09/10/2008EP1966197A2 Processes for preparing palonosetron salts
09/09/2008US7423061 Anticarcinogenic agents; tert-butyl 3-{[(2-[(aminocarbonyl)amino]-5-{4-[2-(diethylamino)ethoxy]phenyl}-3-thienyl)carbonyl]amino}piperidine-1-carboxylate
09/09/2008CA2412047C Shortened synthesis of 3,3-diarylpropylamine derivatives
09/04/2008US20080214870 Method of Preparing Amine Stereoisomers
09/04/2008US20080214602 N-Biarylamides
09/04/2008US20080214601 2-alkylbenzoxazole carboxamides as 5ht3 modulators
09/04/2008US20080214600 Quaternized Quinuclidine Esters
09/04/2008US20080214591 N-Aryl Diazaspirocyclic Compounds and Methods of Preparation and Use Thereof
09/03/2008EP1963285A1 Bradykinin 1 receptor antagonists
09/03/2008EP1730112B1 3-((hetero)arylsulfonyl)-8'[ (aminoalkyl)oxy]quinolines as 5-ht6 receptor antagonists for the treatment of cns disorders
09/03/2008EP1262477B1 Anti-acid-fast bacterial agents containing pyridonecarboxylic acids as the active ingredient
09/03/2008CN101258151A Synthetic methods and intermediates for stereoisomeric compounds useful for the treatment of gastrointestinal and central nervous system disorders
09/03/2008CN101255162A Adenosine receptor antagonists and methods of making and using the same
09/03/2008CN101255157A Crystal system of chlorhydric acid palonosetron and preparation method thereof
08/2008
08/27/2008EP1960397A2 Crystalline forms of palonosetron hydrochloride
08/27/2008EP1349858B1 Agents useful for reducing amyloid precursor protein and treating demantia and methods of use thereof
08/26/2008US7417152 4-Bromo-5-(2-chloro-benzoylamino)-1H-pyrazole-3-carboxylic acid (2-pyrrolidin-1-yl-ethyl)-amide; 5-(2-chlorobenzoylamino)-1H-pyrazole-3-carboxylic acid {2-[4-(4,5-dihydro-1H-imidazol-2-yl)-phenyl]ethyl}amide; useful for the moderation of pain, septic shock, and scarring
08/26/2008US7417050 Cognition activators; Alzheimer's disease; attention deficit disorders; Parkinson's disease; Huntington's disease; neurodegenerative disease
1 ... 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 ... 58